Showing the single result

    The Cunningham Panel


    The Cunningham Panel™ helps physicians identify whether an autoimmune dysfunction may be causing a person’s neuropsychiatric symptoms.

    The panel measures levels of autoantibodies attacking certain proteins in the brain, including those that stimulate brain cells to increase production of excess neurotransmitters, triggering inflammation and abnormal behaviors. High levels of these autoantibodies indicate an individual may have an infection-induced autoimmune disorder.

    Mental illness, behavioral disorder, or an autoimmune problem?

    In some individuals, common infections, like strep, influenza, mycoplasma pneumonia and sinusitis, can trigger an autoimmune dysfunction causing inflammation in the brain and a variety of neurologic and psychiatric symptoms, such as OCD, tics, ADHD, depression and behaviors associated with autism spectrum disorder.

    Infection-induced autoimmune disorders

    The connection between autoimmune dysfunction and psychiatric illnesses has been investigated for many years. Recently, studies have shown that in some cases, there may be a biological basis for certain neuropsychiatric disorders, including schizophrenia and chronic depression. Other studies have found that infection-triggered autoimmune disorders may be the root cause of numerous neuropsychiatric symptoms.

    Researchers believe a number of children and youth who have been diagnosed with a neuropsychiatric illness may actually suffer from an infection-induced autoimmune disorder, which triggers neurologic and psychiatric symptoms, such as OCD, tics, eating disorders and ADHD.

    The Cunningham PanelTM, developed and offered exclusively through Moleculera Labs, is the first test of its kind in the world. The Panel is one, out of several to be introduced, which assists physicians in determining the likelihood that a patient’s neuropsychiatric symptoms are due to an infection-triggered autoimmune response, rather than a primary psychiatric disorder.